• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷 Rd 通过灭活 MAPK 信号通路和诱导黏着斑形成发挥抗转移作用。

Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation.

机构信息

Department of Biotechnology, Bioenergy Research Center, Chonnam National University, 300 Yongbong-Dong, Buk-Gu, Gwangju 500-757, South Korea.

出版信息

Phytomedicine. 2012 Feb 15;19(3-4):284-92. doi: 10.1016/j.phymed.2011.08.069. Epub 2011 Oct 5.

DOI:10.1016/j.phymed.2011.08.069
PMID:21982435
Abstract

Ginsenoside Rd is a protopanaxadiol-type ginsenoside found in ginseng and is the active ingredient in several Oriental herbal medicines. We investigated the effects of ginsenoside Rd on tumor invasion and metastasis in the human hepatocellular carcinoma HepG2 and its possible mechanism of action. HepG2 cells were treated with ginsenoside Rd at different concentrations. Scratch wound and Boyden chamber assays were used to determine the effects of ginsenoside Rd on the migration and invasiveness of HepG2 cells, respectively. The molecular mechanisms by which ginsenoside Rd inhibited the invasion and migration of HepG2 cells were investigated by RT-PCR, Western blotting, gelatin zymography, promoter assay, and treatment with inhibitors of MAPK signaling. Immunofluorescence analysis was conducted to evaluate the effect of ginsenoside Rd on focal adhesion formation in HepG2 cells. Treatment with ginsenoside Rd dose- and time-dependently inhibited the migration and invasion of HepG2 cells. It achieved this by reducing the expression of MMP-1, MMP-2, and MMP-7, by blocking MAPK signaling by inhibiting the phosphorylation of ERK and p38 MAPK, by inhibition of AP-1 activation, and by inducing focal adhesion formation and modulating vinculin localization and expression. Treatment of HepG2 cells with ginsenoside Rd significantly inhibited metastasis, most likely by blocking MMP activation and MAPK signaling pathways involved in cancer cell migration. These findings may be useful for the development of novel chemotherapeutic agents for the treatment of malignant cancers.

摘要

人参中的人参皂甙 Rd 是一种原人参二醇型皂甙,是几种东方草药的有效成分。我们研究了人参皂甙 Rd 对人肝癌 HepG2 细胞侵袭和转移的影响及其可能的作用机制。用不同浓度的人参皂甙 Rd 处理 HepG2 细胞。划痕实验和 Boyden 室分析分别用于确定人参皂甙 Rd 对 HepG2 细胞迁移和侵袭的影响。通过 RT-PCR、Western blotting、明胶酶谱分析、启动子测定以及 MAPK 信号转导抑制剂处理,研究了人参皂甙 Rd 抑制 HepG2 细胞侵袭和迁移的分子机制。免疫荧光分析用于评估人参皂甙 Rd 对 HepG2 细胞焦点黏附形成的影响。用人参皂甙 Rd 处理 HepG2 细胞,呈剂量和时间依赖性地抑制其迁移和侵袭。其作用机制可能是通过降低 MMP-1、MMP-2 和 MMP-7 的表达,通过抑制 ERK 和 p38 MAPK 的磷酸化来阻断 MAPK 信号转导,通过抑制 AP-1 激活,通过诱导焦点黏附形成并调节 vinculin 定位和表达来实现的。用人参皂甙 Rd 处理 HepG2 细胞可显著抑制转移,这很可能是通过阻断 MMP 激活和参与癌细胞迁移的 MAPK 信号通路来实现的。这些发现可能有助于开发用于治疗恶性癌症的新型化疗药物。

相似文献

1
Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation.人参皂苷 Rd 通过灭活 MAPK 信号通路和诱导黏着斑形成发挥抗转移作用。
Phytomedicine. 2012 Feb 15;19(3-4):284-92. doi: 10.1016/j.phymed.2011.08.069. Epub 2011 Oct 5.
2
Anti-invasion and anti-metastasis effects of Valjatrate E via reduction of matrix metalloproteinases expression and suppression of MAPK/ERK signaling pathway.Valjatrate E 通过降低基质金属蛋白酶表达和抑制 MAPK/ERK 信号通路发挥抗侵袭和抗转移作用。
Biomed Pharmacother. 2018 Aug;104:817-824. doi: 10.1016/j.biopha.2018.04.136. Epub 2018 Apr 25.
3
Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells.人参皂苷 Rh1 通过抑制人肝癌细胞中激活蛋白-1 和丝裂原活化蛋白激酶信号通路抑制基质金属蛋白酶-1 的表达。
Eur J Pharmacol. 2012 Mar 15;679(1-3):24-33. doi: 10.1016/j.ejphar.2012.01.020. Epub 2012 Jan 31.
4
Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.溶血磷脂酸通过P38丝裂原活化蛋白激酶途径增强人肝癌细胞的迁移、侵袭和黏附。
Hepatogastroenterology. 2012 May;59(115):785-9. doi: 10.5754/hge11427.
5
Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.人参皂苷20-Rg3的立体特异性作用抑制TGF-β1诱导的上皮-间质转化并抑制肺癌的迁移、侵袭和失巢凋亡抗性。
Toxicology. 2014 Aug 1;322:23-33. doi: 10.1016/j.tox.2014.04.002. Epub 2014 May 2.
6
Wound-healing effect of ginsenoside Rd from leaves of Panax ginseng via cyclic AMP-dependent protein kinase pathway.人参叶中人参皂苷 Rd 通过环腺苷酸依赖的蛋白激酶通路的愈合作用。
Eur J Pharmacol. 2013 Feb 28;702(1-3):285-93. doi: 10.1016/j.ejphar.2013.01.048. Epub 2013 Feb 8.
7
Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.人参皂苷Rh2对人星形胶质瘤细胞基质金属蛋白酶基因表达的抑制作用
Biochem Pharmacol. 2007 Dec 3;74(11):1642-51. doi: 10.1016/j.bcp.2007.08.015. Epub 2007 Aug 19.
8
Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells.人参皂苷 Rg3 通过抑制 PC-3M 前列腺癌细胞中水通道蛋白 1 的表达来抑制细胞迁移。
Eur J Pharmacol. 2012 May 15;683(1-3):27-34. doi: 10.1016/j.ejphar.2012.02.040. Epub 2012 Mar 7.
9
Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma.柚皮苷通过抑制人胶质母细胞瘤中的ERK-P38-JNK信号通路来抑制细胞转移和基质金属蛋白酶(MMP-2和MMP-9)的表达。
Chem Biol Interact. 2016 Jan 25;244:195-203. doi: 10.1016/j.cbi.2015.12.011. Epub 2015 Dec 22.
10
Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.人参皂苷 Rh2 对胰腺癌细胞生长和迁移的影响。
World J Gastroenterol. 2013 Mar 14;19(10):1582-92. doi: 10.3748/wjg.v19.i10.1582.

引用本文的文献

1
Ginsenoside Rd reduces cell proliferation of non-small cell lung cancer cells by p53-mitochondrial apoptotic pathway.人参皂苷Rd通过p53-线粒体凋亡途径降低非小细胞肺癌细胞的增殖。
Heliyon. 2024 Jun 5;10(11):e32483. doi: 10.1016/j.heliyon.2024.e32483. eCollection 2024 Jun 15.
2
Natural Products as Regulators against Matrix Metalloproteinases for the Treatment of Cancer.天然产物作为基质金属蛋白酶调节剂用于癌症治疗
Biomedicines. 2024 Apr 3;12(4):794. doi: 10.3390/biomedicines12040794.
3
Ginsenoside Rd Induces Differentiation of Myeloid Leukemia Cells via Regulating ERK/GSK-3β Signaling Pathway.
人参皂苷 Rd 通过调控 ERK/GSK-3β 信号通路诱导髓系白血病细胞分化。
Chin J Integr Med. 2024 Jul;30(7):588-599. doi: 10.1007/s11655-023-3561-z. Epub 2023 Dec 12.
4
Holothurin A Inhibits RUNX1-Enhanced EMT in Metastasis Prostate Cancer via the Akt/JNK and P38 MAPK Signaling Pathway.海参素 A 通过 Akt/JNK 和 P38 MAPK 信号通路抑制转移前列腺癌中 RUNX1 增强的 EMT。
Mar Drugs. 2023 Jun 3;21(6):345. doi: 10.3390/md21060345.
5
Ginsenoside Rb1 from Suppressed TNF-α-Induced Matrix Metalloproteinase-9 via the Suppression of Double-Strand RNA-Dependent Protein Kinase (PKR)/NF-κB Pathway.人参皂苷 Rb1 通过抑制双链 RNA 依赖性蛋白激酶(PKR)/NF-κB 通路抑制 TNF-α 诱导的基质金属蛋白酶-9。
Molecules. 2022 Nov 19;27(22):8050. doi: 10.3390/molecules27228050.
6
MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma.MMP1 过表达促进头颈部癌的进展并与不良预后相关。
Comput Math Methods Med. 2022 Sep 5;2022:3058342. doi: 10.1155/2022/3058342. eCollection 2022.
7
Biotransformation, Pharmacokinetics, and Pharmacological Activities of Ginsenoside Rd Against Multiple Diseases.人参皂苷Rd对多种疾病的生物转化、药代动力学及药理活性
Front Pharmacol. 2022 Jul 19;13:909363. doi: 10.3389/fphar.2022.909363. eCollection 2022.
8
Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd.人参皂苷 Rd 的生物转化及药理活性的最新研究进展
Biomolecules. 2022 Mar 28;12(4):512. doi: 10.3390/biom12040512.
9
Saponins in Cancer Treatment: Current Progress and Future Prospects.皂苷在癌症治疗中的研究进展与未来展望
Pathophysiology. 2021 Jun 5;28(2):250-272. doi: 10.3390/pathophysiology28020017.
10
The promising therapeutic potentials of ginsenosides mediated through p38 MAPK signaling inhibition.人参皂苷通过抑制p38丝裂原活化蛋白激酶信号传导介导的潜在治疗潜力。
Heliyon. 2021 Nov 12;7(11):e08354. doi: 10.1016/j.heliyon.2021.e08354. eCollection 2021 Nov.